Strides Pharma Science

Strides Pharma Science Treasury Stock

The Treasury Stock of Strides Pharma Science (STAR.NS) as of Nov 22, 2026 is 1.99 B INR. In the previous year, Treasury Stock was 1.93 B INR — a change of 2.99% (higher).

Treasury Stock

1.99 BINR

YoY

2.99%

Last updated:

Treasury Stock of Strides Pharma Science is 2025 1.99 B INR. Treasury Stock of Strides Pharma Science was 2024 1.93 B INR. It decreases by 2.99% higher compared to the previous year.

The Strides Pharma Science Treasury Stock history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Treasury Stock
Date
Treasury Stock
Jan 1, 2018
1.08 B INR
Jan 1, 2019
339.00 M INR
Jan 1, 2020
837.00 M INR
Jan 1, 2021
674.00 M INR
Jan 1, 2022
1.19 B INR
Jan 1, 2023
1.90 B INR
Jan 1, 2024
1.93 B INR
Jan 1, 2025
1.99 B INR
The Strides Pharma Science Treasury Stock history
YEARTreasury StockYoY
1.99 BINR+2.99%
1.93 BINR+1.34%
1.90 BINR+59.61%
1.19 BINR+76.85%
674.00 MINR-19.47%
837.00 MINR+146.90%
339.00 MINR-68.47%
1.08 BINR-69.40%
3.51 BINR-19.04%
4.34 BINR-6.75%
4.65 BINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Strides Pharma Science Stock analysis

What does Strides Pharma Science do? Strides Pharma Science Ltd. generates revenue through the development, manufacturing, and distribution of IP-led generics and bio-pharmaceutical products across its Pharmaceutical and Bio-pharmaceutical segments. The company serves global markets including Africa, Australia, Asia (excluding India), North America, Europe, India, and Others, offering niche pharmaceutical products in various dosage forms such as liquids, creams, ointments, soft gels, sachets, tablets, and modified release formats. Its manufacturing units in Bengaluru, Puducherry, Chennai, Singapore, Milan, Florida, and Nairobi produce anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drugs, alongside soft gelatin capsules. The firm's revenue streams are derived from the sale of its IP-led niche pharmaceutical products to healthcare providers, distributors, and global pharmaceutical companies operating in the specified geographical segments. Key product categories include anti-retroviral, anti-malarial, anti-tuberculosis, and hepatitis treatments, which are distributed through its global manufacturing network. The company's focus on specialized drug segments ensures consistent demand from healthcare systems and institutions managing infectious diseases. Strides Pharma Science Ltd. targets healthcare institutions, distributors, and pharmaceutical companies in regions such as North America, Europe, India, and Africa, where infectious disease management requires specialized treatments. Its manufacturing presence in multiple countries supports direct market access and cost efficiency, enabling the delivery of affordable pharmaceutical solutions. The company's product portfolio emphasizes high-demand therapeutic areas, aligning with global health priorities for infectious disease treatment. Strides Pharma Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Strides Pharma Science stock

Treasury Stock of Strides Pharma Science is 1.99 B INR in 2025.

Treasury Stock of Strides Pharma Science changed from 1.93 B INR to 1.99 B INR, representing a 2.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Treasury Stock Strides Pharma Science since 2006 – with annual values, charts, and detailed analysis.

Treasury stock represents shares that were repurchased by the company. It reduces shareholders' equity and outstanding share count.

Treasury Stock's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Treasury Stock's Strides Pharma Science historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Strides Pharma Science

All Key Metrics — Strides Pharma Science